In vivo veritas: Pathogenesis of infection as it actually happens

Nature Immunology

Volumn 8, Issue 11, 2007, Pages 1143-1147

  Virgin, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG FEVER; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HELICOBACTER PYLORI; HEPATITIS C; HOST PATHOGEN INTERACTION; HUMAN; IN VIVO STUDY; INFECTION; INNATE IMMUNITY; LIVER CELL CARCINOMA; MUTAGENESIS; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RNA VIRUS; SYMBIOSIS; VIRUS GENE; VIRUS REPLICATION; VIRUS VIRULENCE;

ALLERGY AND IMMUNOLOGY; ANIMALS; HOST-PARASITE INTERACTIONS; HUMANS; INFECTION; MICROBIOLOGY; VIRULENCE;

EID: 35649014966     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1529     Document Type: Review

References (40)

1. McGeoch, D.J., Rixon, F.J. & Davison, A.J. Topics-herpesvirus genomics and evolution. Virus Res. 117, 90-104 (2006).
2. Ahmed, R., Oldstone, M.B.A. & Palese, P. Protective immunity and susceptibility to infectious diseases: Lessons from the 1918 influenza pandemic. Nat. Immunol. 8, 1188-1193(2007).
3. Zampieri, C.A., Sullivan, N.J. & Nabel, G.J. Immunopathology of highly virulent pathogens: Insights from Ebola virus. Nat. Immunol. 8 1159-1164 (2007).
4. Roy, C.R. & Mocarski, E.S. Pathogen subversion of cell-intrinsic innate immunity. Nat. Immunol. 8, 1179-1187 (2007).
5. Quintana-Murci, L., AlcaTs, A., Abel, L. & Casanova, J.-L. Immunology in natura: Clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol. 8, 1165-1171 (2007).
6. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007).
7. Rioux, J.D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604 (2007).
8. Yates, J.R. et al. Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 357, 553-561 (2007).
9. Jiang, N., Tan, N.S., Ho, B. & Ding, J.L. Respiratory protein-generated reactive oxygen species as an antimicrobial strategy. Nat Immunol. 8, 1114-1122 (2007).
10. McMichael, A.J. From influenza to HIV - and back? Nat. Immunol. 8, 1149-1151 (2007).
11. Braaten, D.C. etal. Effective control of chronic gamma-herpesvirus infection by unconventional MHC class la-independent CD8T cells. Plos Pathogens 2, e37 (2006).
12. Moretta, L., Romagnani, C., Pietra, G., Moretta, A. & Mingari, M.C. NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol. 24, 136-143 (2003).
13. + cytolytic T lymphocytes. Proc. Natl. Acad. Sci. USA 100, 10896-10901 (2003).
14. Karst, S.M., Wobus, C.E., Lay, M., Davidson, J. & Virgin, H.W. STAT-1-dependent innate immunity to a Norwalk-like virus. Science 299, 1575-1578 (2003).
15. Wobus, C.E. et al. Replication of a norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2, e432 (2004).
16. Hsu, C.C., Wobus, C.E., Steffen, E.K., Riley, L.K. & Livingston, R.S. Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice. Clin. Diagn. Lab. Immunol. 12 1145-1151 (2005).
17. Thackray, L.B. et al. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J. Virol. 81, 10460-10473 (2007).
18. Lecuit, M. et al. A transgenic model forllisteriosis: Role of internalin in crossing the intestinal barrier. Science 292, 1722-1725 (2001).
19. Ren, R.B., Costantini, F., Gorgacz, E.J., Lee, J.J. & Racaniello, V.R. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis. Cell 63, 353-362 (1990).
20. Wang, F. et al. Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nat. Immonol. 5, 1266-1274 (2004).
21. Allander, T. et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. USA 102, 12891-12896 (2005).
22. Allander, T. et al. Identification of a third human polyomavirus. J. Virol. 81, 4130-4136 (2007).
23. Gaynor, A.M. et al. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS. Pathogens 3, e64 (2007).
24. Leib, D.A., Machalek, M.A., Williams, B.R., Silverman, R.H. & Virgin, H.W. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci. USA 97, 6097-6101 (2000).
25. Virgin, H.W. Pathogenesis of viral infection. in Fields Virology (eds. Knipe, D.M. & Howley, P.M.) 327-388 (Lippincott Williams & Wilkins, Philadelphia, 2007).
26. Lysenko, E.S., Ratner, A.J., Nelson, A.L. & Weiser, J.N. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS. Pathogens 1, e1 (2005).
27. Ratner, A.J., Lysenko, E.S., Paul, M.N. & Weiser, J.N. Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc. Natl. Acad. Sci. USA 102, 3429-3434 (2005).
28. Barton, E.S. et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326-329 (2007).
29. Pamer, E.G. Immune responses to commensal and environmental microbes. Nat. Immunol. 8, 1173-1178 (2007).
30. Velazquez, P., Waite, J.C. & Dustin, M.L. Dynamics of host defense: The view at the front lines. Nat. Immunol. 8, 1153-1157 (2007).
31. Steed, A.L. et al. Gamma interferon blocks gammaherpesvirus reactivation from latency. J. Virol. 80, 192-200 (2006).
32. Tibbetts, S.A., Van Dyk, L., Speck, S.H. & Virgin, H.W. Immune control of the number and reactivation phenotype of cells latently infected with a gamma-herpesvirus. J. Virol. 76, 7125-7132 (2002).
33. Sarawar, S.R. et al. Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J. Virol. 71, 3916-3921 (1997).
34. Dal Canto, A.J., Swanson, P.E., O'Guin, A.K., Speck, S.H. & Virgin, H.W. IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J. Clin. Invest. 107, R15-R22 (2001).
35. Weck, K.E. et al. Murine gammaherpesvirus 68 causes severe large vessel arteritis in mice lacking interferon-gamma responsiveness: A new model for virus induced vascular disease. Nat. Med. 3, 1346-1353 (1997).
36. Gangappa, S., Van Dyk, L.F, Jewett, T.J, Speck, S.H. & Virgin, H.W. Identification of the in vivo role of a viral bcl-2. J. Exp. Med. 195, 931-940 (2002).
37. Van Dyk, L.F., Virgin, H.W. & Speck, S.H. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J. Virol. 74, 7451-7461 (2000).
38. Tscharke, D.C., Reading, P.C. & Smith, G,L. Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J. Gen. Virol. 83, 1977-1986 (2002).
39. Alcami, A. & Smith, G.L. A mechanism for the inhibition of fever by a virus. Proc. Natl. Acad. Sci. USA 93, 11029-11034 (1996).
40. Alcami, A. & Smith, G.L. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167 (1992).